Recursion Pharmaceuticals Inc (RXRX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -122.012 | -43.501 | -41.033 | -36.516 | -48.423 |
Return on Equity (%) | 99.592 | 52.643 | -110.785 | -46.557 | -69.122 |
Return on Invested Capital (%) | -140.952 | -49.059 | -46.333 | -47.873 | -71.569 |
Operating Margin (%) | -2640.966 | -2161.686 | -1803.174 | -600.911 | -744.882 |
Net Profit Margin (%) | -2668.348 | -2196.012 | -1832.177 | -601.049 | -735.987 |
Book Value Per Share | 5.327 | 16.102 | 1.588 | 1.42 | 0.868 |
Earnings Per Share | -4.29 | -5.849 | -0.548 | -0.703 | -0.76 |
Cash Per Share | 4.845 | 17.621 | 0.837 | 1.615 | 0.907 |
Working Capital Per Share | 4.833 | 16.562 | 1.433 | 1.379 | 0.799 |
Operating Profit Per Share | 0.161 | 0.266 | 0.03 | 0.01 | 0.061 |
EBIT Per Share | -4.29 | -5.849 | -0.548 | -0.703 | -0.769 |
EBITDA Per Share | -4.29 | -5.849 | -0.548 | -0.703 | -0.769 |
Free Cash Flow Per Share | -4.264 | -5.695 | -0.457 | -0.628 | -0.787 |
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | N/A | N/A | 160,91M | 160,91M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
Actions en circulation | 160,91M | N/A | N/A | N/A | N/A | 230,27M | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -538.223 | N/A | N/A | N/A | -667.914 | N/A | N/A |
Net Profit Margin (%) | N/A | -538.38 | N/A | N/A | N/A | -662.411 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 1,75B |
Ratio cours/bénéfice | -5,27 |
Ratio prix/ventes | 38,78 |
Ratio prix/liquidités | 4,41 |
Ratio prix/valeur comptable | 3,73 |
Rendement de dividende | - |
Actions en circulation | 286,64M |
Volume moyen (1 semaine) | 15,96M |
Volume moyen (1 mois) | 16,14M |
Variation sur 52 semaines | -39,28% |
Plus haut sur 52 semaines | 15,74 |
Plus bas sur 52 semaines | 5,60 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales